March 12, 2010 – In partnership with the American College of Cardiology (ACC), Philips is spotlighting the growing need for hybrid cath labs with a specialty exhibit during ACC 2010 March 14-16 in Atlanta. The need to reduce invasive surgical interventions and complication rates is driving innovations in minimally invasive approaches. Philips and ACC will jointly showcase the Hybrid OR Suite on the expo floor, a solution that combines in one room the equipment needed to perform both open and endovascular cardiac procedures. Built out of combined efforts by Philips and its network of alliances, the Hybrid OR Suite will help advance how clinicians attend to patients in cardiac procedures. Traditionally, X-ray imaging is used to navigate cardiac interventions performed in a cardiac catheterization lab. In recent times, importance has grown for 3D ultrasound imaging in visualizing complex structures during interventions. A hybrid OR suite combines the sterility and instruments of a traditional operating room with the X-ray and ultrasound imaging systems and radiation shields of a cath lab. “Using live 3D TEE ultrasound, we can view the anatomy without incisions or surgery,” said Roberto Lang, M.D., director of noninvasive cardiac imaging labs at the University of Chicago Medical Center. “It provides 3D images unlike those from other technology, to help clinicians place therapeutic devices." The cutting-edge hybrid OR configuration not only provides hospitals with a room that is flexible enough to handle a wide variety of treatments and procedures, but it also helps clinicians from a variety of specialties to collaborate. "Multidisciplinary care is gaining broader acceptance as hospitals and healthcare institutions combine approaches and evolve in their delivery of cardiac care,” said Henry Solomon, M.D., chief medical officer for business development at the American College of Cardiology. “Rooms equipped to support both open surgical and minimally invasive endovascular approaches, such as the hybrid OR, are designed to meet the specific needs of clinicians when they are called upon to perform difficult procedures.” The hybrid OR suite on display at this year’s ACC enables clinicians to perform a full range of endovascular, percutaneous and open procedures. Percutaneous procedures enable physicians to utilize minimally invasive catheter-based interventions to treat patients that may be too sick or frail for open interventions, such as in valve replacement surgery. “The patient is happy, the procedure is less invasive and the collaboration between the cardiologist, the cardiac surgeons and industry—with Philips providing the technology—has made that possible,” said Valluvan Jeevanandam, M.D., chief of cardiac and thoracic surgery at the University of Chicago Medical Center. Philips’ hybrid OR suites are customized for customer needs and designed using an advanced 3D architectural planning tool that provides prospective customers with a visual rendering of possible room configurations. From high-quality, high-resolution, multimodality imaging with advanced 3D software to support confident decision-making, to surgical tables, lighting and other equipment considerations, the full scope of equipment combinations is assessed. The Philips Healthcare booth is 1343, and the Hybrid OR Suite is located in booth 2744. Online visitors can visit http://www.philips.com/media or www.philips.com/hybridor
Feature | March 11, 2010
Hybrid Cath Lab Exhibit at ACC Highlights Growing Trend
Feature | Business| February 10, 2016 | Dave Fornell
After five years of almost constant lobbying efforts and numerous attempts by the U.S.
News | Stents| February 10, 2016
CeloNova BioSciences Inc. announced this week that the first patient has been enrolled in its COBRA REDUCE trial. The...
News | Stem Cell Therapies| February 09, 2016
Columbia Engineering researchers have shown, for the first time, that electrical stimulation of human heart muscle...
News | ACC| February 09, 2016
February 9, 2016 — The late-breaking clinical trial presentations have been announced for the 2016 American College o
Feature | Heart Valve Repair| February 08, 2016 | Dave Fornell
Off-label use of the St.
News | EP Lab| February 04, 2016
Contrary to current clinical belief, regular caffeine consumption does not lead to extra heartbeats, which, while...
Technology | Cath Lab| February 04, 2016
February 4, 2016 — Stereotaxis and Philips have signed an addendum pursuant to their existing Development and Coopera
News | Implantable Cardioverter Defibrillators (ICD)| February 03, 2016
Biotronik announced CE approval for its new Ilivia implantable cardioverter defibrillators (ICDs) and cardiac...
News | February 03, 2016 | Dave Fornell
Medtronic announced Feb. 3 that the U.S.
News | Stents Drug Eluting| February 02, 2016
Medtronic plc announced the recent CE Mark and commercial launch for an expanded size matrix of the Resolute Onyx DES,...